Cargando…
Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Review Study
Background: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are neoplasms derived from the endocrine system in the gastrointestinal tract and pancreas. Treatment options include surgery; pharmacological treatments like somatostatin analogues (SSA), interferon alpha, molecular targeted thera...
Autores principales: | Lesén, Eva, Granfeldt, Daniel, Berthon, Anthony, Dinet, Jérôme, Houchard, Aude, Myrenfors, Peter, Björstad, Åse, Björholt, Ingela, Elf, Anna-Karin, Johanson, Viktor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909946/ https://www.ncbi.nlm.nih.gov/pubmed/31839822 http://dx.doi.org/10.7150/jca.32381 |
Ejemplares similares
-
Cost‐of‐illness of metastatic gastroenteropancreatic neuroendocrine tumours in Sweden—A population‐based register‐linkage study
por: Lesén, Eva, et al.
Publicado: (2019) -
Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study
por: Ambring, Anneli, et al.
Publicado: (2012) -
Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours – an analysis based on the CLARINET study
por: Meng, Yang, et al.
Publicado: (2017) -
MON-301 Long-Acting SSA Treatment Patterns in Sweden From 2005 to 2017: A Nationwide Study
por: Olsson, Daniel S, et al.
Publicado: (2020) -
Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)
por: Ström, Torbjörn, et al.
Publicado: (2019)